Saffron Supplementation for Dry AMD: Italy


Description: The Catholic University of the Sacred Heart in Italy is conducting a 30-person clinical trial of saffron for the treatment of dry age-related macular degeneration (AMD). Saffron contains high concentrations of crocin and crocetin, compounds with anti-oxidative properties. Saffron supplementation has inhibited retinal degeneration in lab studies.

Trial Status: Recruiting participants.

Partial List of Participation Criteria:

  1. 55 years of age or older
  2. Diagnosis of early dry AMD

Clinical Trial Contact:
Benedetto Falsini, M.D.
Phone: 0039063015 ext. 4929
Policlinico A. Gemelli
Rome, Italy

Additional Information:
Saffron clinical trial for dry AMD listing on